Extra boost for Nuclidium: financing round reaches €115 million
The Swiss radiopharma company Nuclidium AG has closed an oversubscribed extension of CHF 26.4 million to its Series B round from last year, raising a total of CHF 105 million (around €115 million). The round was led by existing investors Kurma Growth Opportunities Fund, Angelini Ventures together with the EIB co-investment facility Aurea, Wellington Partners, and Neva SGR (Intesa Sanpaolo Group). Additional participation came from DeepTech & Climate Fonds (DTCF), Bayern Kapital, Vives Partners, and NRW.Bank.
A Connected Ecosystem Powering the Next Wave of Agri-food Innovation
By the Queensland GovernmentAround the world, agri-food innovation sometimes struggles to move beyond early-stage ideas. Queensland is stepping forward as a place where innovation is both generated and scaled.
Targeting Metabolic Mechanism Restores Chemotherapy Sensitivity in Ovarian Cancer
Although many cancers can be successfully treated using platinum-based chemotherapies, which work by damaging DNA, a subset avoid cell death by repairing their own DNA. Ovarian cancers are an example. Patients whose tumors are DNA repair proficient historically face poor prognosis and their tumors commonly recur within months.
GSK reports 19% functional cure rate for near-approval hepatitis B drug
The placebo-controlled trials assessed the ability of bepirovirsen, an antisense oligonucleotide targeting hepatitis B transcripts, to cause functional cures in adults with noncirrhotic chronic infections. Across the two studies, GSK randomized more than 1,800 people to receive subcutaneous bepirovirsen or placebo weekly for 24 weeks.
Agritechnica Asia closed successfully
Agritechnica Asia, organized by DLG (German Agricultural Society), took place from May 20-22. The event brought together international exhibitors, dealers, buyers and industry experts at the Bangkok International Trade & Exhibition Centre (BITEC), Thailand. Together with the co-located HortEx exhibition, Agritechnica Asia confirmed its role as platform for innovation, business development, technology transfer and knowledge exchange across Asia.
读懂市场、读懂法规、读懂农民需求——巴斯夫的创新逻辑,不是从实验室出发
一个全新结构的三唑类分子,如何在全球数十个国家精准填补市场空白、实现规模化商业突破?当中国农化行业加速向创制时代转型,巴斯夫走过的这条路,成为值得深度研究的样本。
FAO Opens Applications for 2026 Global AgriInno Challenge with $30,000 Prize
Applications are open for the FAO Global AgriInno Challenge 2026, an international competition supporting startups, researchers, and innovation teams developing technology-driven solutions for sustainable agrifood systems.
SDF Group keeping well on track
Throughout 2025, SDF consolidated its global position by further increasing its market share. This result confirms the effectiveness of its growth strategy, despite an industry environment characterised by an overall decline in sales volumes.
Oishii Secures $150 Million in Series C First Closing to Advance Smart Farm™ Innovation
By Editor, Global AgInvesting MediaVertical farming pioneer Oishii has announced the first closing of its $150 million Series C financing round. This latest capital injection marks a transition into a mature phase of commercial growth for the company, which operates the world’s largest indoor vertical strawberry farm. According to its press release, the funding will be utilized to ramp up production capacity, optimize automation infrastructure, and widen retail access across both the United States and Japan.
江苏禾本苯醚甲环唑原药获得巴西自主登记
世界农化网中文网报道:近日,江苏禾本生化有限公司的苯醚甲环唑原药正式获得巴西农业部(MAPA)颁发的自主登记证,证号为TC12626,商品名为DIFENOCONAZOLE TÉCNICO HEBEN。这是继该产品获得自主欧盟等同登记后,禾本在全球农化主流市场取得的又一关键突破。
